MONOLISA™ Anti-HAV IgM EIA

Print

Overview

Hepatitis A Serology

Serology Profiles

Hepatitis A: Example of Acute Hepatitis

Hepatitis Testing

Comprehensive Product Line for Hepatitis Testing

   
Fast incubation time:
2.5 hours
  Standardized procedure
for all Bio-Rad assays
  Microplate strip identification
   
Common reagents for
all Bio-Rad kits
  Color-coded reagent
and kit labels
  Color changes during
protocol steps
   
Manual and automated use   Barcoded reagents   Controls with
color-coded caps

MONOLISA™ Anti-HAV IgM EIA is for the detection of IgM antibodies to hepatitis A virus (HAV) in human (adult or pediatric) serum or plasma. Specific IgM antibodies to HAV (anti-HAV IgM) appear a few days after infection, reach a peak rapidly, and persist at elevated levels in the bloodstream for about two months, before declining during late convalescence. The recent availability of anti-HAV vaccines has prompted the development of more sensitive assays, used for screening unvaccinated individuals, to follow up on antibody response after vaccination, and to estimate the need and timing of booster vaccinations. Specificity in hepatitis testing is critical—trust Bio-Rad’s expertise in immunology and continually updated reagents for all hepatitis testing needs.

MONOLISA™ Anti-HAV IgM EIA
MONOLISA™ Anti-HAV IgM EIA

72495
192 tests for detection of IgM antibodies to hepatitis A virus in human (adult and pediatric) serum or plasma

List Price:   Inquire
Quantity:   Add to Quote